Patentability of a product or process requires novelty, inventive step and industrial utility. Relevant to genomics and its application to inventions for treatment and diagnosis of COVID-19, the Philippine Intellectual Property Code (“IP Code”) provides what are patentable, and what are not.
In the article entitled: “Patentability Considerations for COVID-19 Related Genomics” as published in the Asian Patent Attorneys Association ("APAA") e-Newsletter for April 2021, the Firm's
Sophie Cruz-Abrenica and
Maria Patricia P. Cruz discuss the patentability considerations in utilizing genomics in search for a solution to the COVID-19 pandemic.
The APAA is a non-governmental organization dedicated to promoting and enhancing intellectual property protection in the region, whose members include some of Asia’s leading practitioners of intellectual property law. With its large pool of members and expertise, APAA is well placed to play an influential role in promoting and enhancing intellectual property protection in the Asian Region.
